Research Article
Zinc Oxide Nanoparticle Synergizes Sorafenib Anticancer Efficacy with Minimizing Its Cytotoxicity
Table 2
Hematological and biochemical parameters. Values are expressed as of 10 animals in each group.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SD: standard deviation; : probability; ; high significance. The test used one-way ANOVA followed by post hoc Tukey. aSignificant compared to the control group. bSignificant compared to the control SEC group. cSignificant compared to the MTX group. dSignificant compared to the ZnO-NP group. eSignificant compared to the sorafenib group. |